Status: Recruiting
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Safety, tolerability and efficacy of Descarte-08 in children, adolescents and young adults with childhood-onset systemic lupus erythematosus, ANCA-associated vasculitis, juvenile myasthenia gravis, and juvenile dermatomyositis
Participants needed: 50
Trial details
Phase: Phase 1, Phase 2Age: 12+Biological sex: AllType: InterventionalSponsor: Cartesian TherapeuticsUpdated: Apr 8, 2026Locations: 2
Eligibility criteria
At least age 12 [+4]
Major chronic illness that is not well managed at the time of study entry and in... [+12]